Demonstrates improved locomotor function in spinal cord injury, suggesting a novel therapeutic approach.
, Que@MCEu/H markedly reduces lesion cavities and fibrotic scarring in a mouse contusion SCI model, suppresses GFAP-positive glial scar formation, and promotes axonal regeneration and angiogenesis, culminating in improved locomotor function. Mechanistically, therapeutic outcomes correlate with upregulation of autophagy/mitophagy markers (Beclin-1, Parkin, LC3B), indicating enhanced clearance of damaged mitochondria and neuronal protection. Collectively, Que@MCEu/H offers a promising, multifunctional platform that couples antioxidation, immunomodulation, and mitochondrial protection to facilitate SCI repair and functional recovery.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: